Folic Acid Supplementation Inhibits Proliferative Retinopathy of Prematurity
Biomolecules · 2025
DOI: 10.3390/biom15020309 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von Shen Nian und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA. Hauptthemen laut MEDLINE: Retinopathy of Prematurity, Folic Acid, Dietary Supplements. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mass Lions Eye Foundation, NEI NIH HHS, Boston Children's Hospital Pilot Grant.
Abstract (Originalsprache)
Background
Retinopathy of prematurity (ROP) is the major cause of blindness in children. It is a biphasic disease with retinal vessel growth cessation and loss (Phase I) followed by uncontrolled retinal vessel growth (Phase II). Folate is an essential nutrient for fetal development and growth. Premature infants have a high risk for folate deficiency. However, the contribution of folate to ROP risk remains unknown.
Methods
In mouse oxygen-induced retinopathy (OIR), the nursing dams were fed with a folic acid-deficient or control diet after delivery until the end of hyperoxia. Alternatively, pups received direct injection of either folic acid or vehicle during Phase I hyperoxia. Genes involved in the folate cycle and angiogenic responses were examined using real-time PCR. Total retinal folate levels were measured with the Lactobacillus casei assay.
Results
Maternal folic acid deficiency in early life exacerbated pathological retinal vessel growth, while supplementation with folic acid suppressed it. Genes involved in the folate cycle were downregulated in Phase I OIR retinas and were highly expressed in Müller glia. Folic acid reduced pro-angiogenic signaling in cultured rat retinal Müller glia in vitro.
Conclusions
Appropriate supplementation of folic acid might be a new and safe treatment for ROP at an early stage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
- Department of Pathology, Xi'an Medical University, Xi'an 710021, China.
- Division of Nutritional Sciences, Cornell University, Ithaca, NY 14853, USA.
- Centre Hospitalier Universitaire Sainte-Justine Research Center, Montreal, QC H3T 1C5, Canada.
- Department of Ophthalmology, Keio University School of Medicine, Tokyo 160-8582, Japan.
- Eye Center, Medical Center, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.
ORCID-Profile: Shen Nian, Yan Zeng, Gaël Cagnone, Myriam Boeck, Deokho Lee, Victoria Hirst, Chaomei Wang, Katherine Neilsen, Zhongjie Fu
Förderung
- Mass Lions Eye Foundation
- NEI NIH HHS
- Boston Children's Hospital Pilot Grant
- Boston Children's Hospital OFD/BTREC/CTREC Faculty Career Development Grant
- Boston Children's Hospital Ophthalmology Foundation
- Boston Children’s Hospital
- OFD/BTREC/CTREC Faculty Career Development
- Pilot Grant
Zitieren
APA
Nian, S., Zeng, Y., Heyden, K. E., Cagnone, G., Yagi, H., Boeck, M., Lee, D., Hirst, V., Hua, Z., Lee, J., Wang, C., Neilsen, K., Joyal, J. S., Field, M. S., & Fu, Z. (2025). Folic Acid Supplementation Inhibits Proliferative Retinopathy of Prematurity. Biomolecules. https://doi.org/10.3390/biom15020309
Vancouver
Nian S, Zeng Y, Heyden KE, Cagnone G, Yagi H, Boeck M, et al. Folic Acid Supplementation Inhibits Proliferative Retinopathy of Prematurity. Biomolecules. 2025. doi:10.3390/biom15020309
BibTeX
@article{Nian2025,
author = {Nian, Shen and Zeng, Yan and Heyden, Katarina E and Cagnone, Gaël and Yagi, Hitomi and Boeck, Myriam and Lee, Deokho and Hirst, Victoria and Hua, Zhanqing and Lee, Jeff and Wang, Chaomei and Neilsen, Katherine and Joyal, Jean-Sébastien and Field, Martha S and Fu, Zhongjie},
title = {Folic Acid Supplementation Inhibits Proliferative Retinopathy of Prematurity},
journal = {Biomolecules},
year = {2025},
doi = {10.3390/biom15020309}
}
EUVIMED